Stepping down inhaled corticosteroids from scheduled to as needed in stable asthma: Systematic review and meta-analysis

摘要

Background:Many patients with asthma are potentially overtreated, which results in unnecessary cost and unnecessary exposure to drugs that may result in adverse events. Step down helps reduce overtreatment, may mitigate these harms, and is advocated by major guidelines. Unfortunately, data that support step down are sparse.